Monash IVF (ASX:MVF) to acquire ART Associates Queensland

Company News

by Lauren Evans

Monash IVF (ASX:MVF) is set to acquire ART Associates Queensland in Brisbane for initial cash consideration of $3.9 million.

According to Monash, ART Associates Queensland includes six fertility specialists who have worked together for several years and will join the Monash IVF clinician network.

The deal includes the potential of additional earn out payments over a five to seven year period from completion.

Following completion, Monash IVF said that it will have attracted eight new fertility specialists in Brisbane during 2022, which complements its ten existing fertility specialists in the Brisbane region.

The deal is set to be completed in September this year, and is expected to be funded through Monash IVF's existing debt facilities.

“The acquisition of ART Associates Queensland, will provide us with strong growth opportunities in the Brisbane region, building on our existing fertility specialists and IVF service teams,” said chief executive officer Michael Knaap.

Shares are trading 4.3 per cent higher at 98 cents. 

Are you a 708 sophisticated investor?

A sophisticated investor is defined under Section 708 of the Corporations Act (net assets of $2.5 million or annual incomes in excess of $250,000).

They are eligible to receive information regarding wholesale investment opportunities that are not available to regular or retail investors.

Please subscribe if you would like to be alerted to these types of opportunities.